These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4476720)

  • 1. Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requirement and on some complications.
    Andreani D; Iavicoli M; Tamburrano G; Menzinger G; Maltarello C
    Horm Metab Res; 1974 Nov; 6(6):447-54. PubMed ID: 4476720
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The place of "monocomponent" insulins in diabetes mellitus therapy].
    Teuscher A
    Schweiz Med Wochenschr; 1975 Apr; 105(16):485-94. PubMed ID: 1215860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin lipoatrophy and its elimination through the use of monocomponent insulin].
    Maaz E
    Z Gesamte Inn Med; 1976 Nov; 31(22):941-5. PubMed ID: 1035452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monocomponent insulins].
    Rodríguez-Miñón JL
    Minerva Med; 1977 Jul; 68(35):2485-90. PubMed ID: 887227
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of purified bovine and monocomponent porcine insulins.
    Johnson Z; McDonnell J; Devlin JG
    Ir Med J; 1984 Dec; 77(12):380-1, 383. PubMed ID: 6394540
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetes mellitus. Its treatment with monocompound purified insulin].
    Mirouze J; Orsetti A; Schmouker Y; Cartry E; Almes N
    Nouv Presse Med; 1973 Sep; 2(30):1981-5. PubMed ID: 4738370
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monocomponent insulins (author's transl)].
    Rodriguez-Miñón JL
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1215-20. PubMed ID: 409943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes.
    Andersen OO
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008
    [No Abstract]   [Full Text] [Related]  

  • 14. [New insulins in diabetes therapy].
    Morell B
    Schweiz Med Wochenschr; 1979 Mar; 109(10):362-5. PubMed ID: 570723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
    Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of monocomponent insulin serum anti-insulin antibody levels (author's transl)].
    García de los Ríos M; Mella I; Durruty P; Ruiz F; López G; Tapia JC; González G
    Rev Med Chil; 1981 Jun; 109(6):509-15. PubMed ID: 7036310
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of efficacy and safety of human insulin (Novo) in the treatment of insulin-dependent diabetes mellitus: a double-blind, multicenter clinical trial.
    Karam J; Brink S; Clements R; Miller L; Raskin P
    Diabetes Care; 1983; 6 Suppl 1():56-60. PubMed ID: 6343041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of soluble porcine and human insulin (Novo) using the artificial pancreas.
    Mirouze J; Benghernaout O; Pham TC; Richard JL; Bringer J
    Diabetes Care; 1983; 6 Suppl 1():40-2. PubMed ID: 6343037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical aspects of monocomponent insulins in the treatment of diabetes.
    Vinik AI; Joffe BI; Seftel HC; Distiller LA; Jackson WP
    S Afr Med J; 1976 Apr; 50(15):587-91. PubMed ID: 1265555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.